These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23587243)

  • 21. Global Landscape and Regulatory Principles of DNA Methylation Reprogramming for Germ Cell Specification by Mouse Pluripotent Stem Cells.
    Shirane K; Kurimoto K; Yabuta Y; Yamaji M; Satoh J; Ito S; Watanabe A; Hayashi K; Saitou M; Sasaki H
    Dev Cell; 2016 Oct; 39(1):87-103. PubMed ID: 27642137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA hypermethylation in somatic cells correlates with higher reprogramming efficiency.
    Barrero MJ; Berdasco M; Paramonov I; Bilic J; Vitaloni M; Esteller M; Izpisua Belmonte JC
    Stem Cells; 2012 Aug; 30(8):1696-702. PubMed ID: 22653871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pluripotency in 3D: genome organization in pluripotent cells.
    Denholtz M; Plath K
    Curr Opin Cell Biol; 2012 Dec; 24(6):793-801. PubMed ID: 23199754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of the Metabolic Shift during Somatic Cell Reprogramming.
    Nishimura K; Fukuda A; Hisatake K
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31067778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TRIM28 is an Epigenetic Barrier to Induced Pluripotent Stem Cell Reprogramming.
    Miles DC; de Vries NA; Gisler S; Lieftink C; Akhtar W; Gogola E; Pawlitzky I; Hulsman D; Tanger E; Koppens M; Beijersbergen RL; van Lohuizen M
    Stem Cells; 2017 Jan; 35(1):147-157. PubMed ID: 27350605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-based discovery of NANOG variant with enhanced properties to promote self-renewal and reprogramming of pluripotent stem cells.
    Hayashi Y; Caboni L; Das D; Yumoto F; Clayton T; Deller MC; Nguyen P; Farr CL; Chiu HJ; Miller MD; Elsliger MA; Deacon AM; Godzik A; Lesley SA; Tomoda K; Conklin BR; Wilson IA; Yamanaka S; Fletterick RJ
    Proc Natl Acad Sci U S A; 2015 Apr; 112(15):4666-71. PubMed ID: 25825768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reprogramming to pluripotency: stepwise resetting of the epigenetic landscape.
    Papp B; Plath K
    Cell Res; 2011 Mar; 21(3):486-501. PubMed ID: 21321600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rearranging the chromatin for pluripotency.
    Ferrari F; Apostolou E; Park PJ; Hochedlinger K
    Cell Cycle; 2014; 13(2):167-8. PubMed ID: 24241209
    [No Abstract]   [Full Text] [Related]  

  • 29. Prevention of tumor risk associated with the reprogramming of human pluripotent stem cells.
    Wuputra K; Ku CC; Wu DC; Lin YC; Saito S; Yokoyama KK
    J Exp Clin Cancer Res; 2020 Jun; 39(1):100. PubMed ID: 32493501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The effect of microRNAs on the regulatory network of pluripotency in embryonic stem cells].
    Bai YS; Li L; Wei HX; Zhu C; Zhang SQ
    Yi Chuan; 2013 Oct; 35(10):1153-66. PubMed ID: 24459889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of transcriptional elongation in pluripotency and cell differentiation by the PHD-finger protein Phf5a.
    Strikoudis A; Lazaris C; Trimarchi T; Galvao Neto AL; Yang Y; Ntziachristos P; Rothbart S; Buckley S; Dolgalev I; Stadtfeld M; Strahl BD; Dynlacht BD; Tsirigos A; Aifantis I
    Nat Cell Biol; 2016 Nov; 18(11):1127-1138. PubMed ID: 27749823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Noncoding RNAs in the Regulation of Pluripotency and Reprogramming.
    Sherstyuk VV; Medvedev SP; Zakian SM
    Stem Cell Rev Rep; 2018 Feb; 14(1):58-70. PubMed ID: 29143182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oct4 resetting by Aurkb-PP1 cell cycle axis determines the identity of mouse embryonic stem cells.
    Shin J; Youn HD
    BMB Rep; 2016 Oct; 49(10):527-528. PubMed ID: 27697110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induced pluripotent stem cells: what lies beyond the paradigm shift.
    Cox JL; Rizzino A
    Exp Biol Med (Maywood); 2010 Feb; 235(2):148-58. PubMed ID: 20404029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upping the ante: recent advances in direct reprogramming.
    Müller LU; Daley GQ; Williams DA
    Mol Ther; 2009 Jun; 17(6):947-53. PubMed ID: 19337233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SIRT2 is required for efficient reprogramming of mouse embryonic fibroblasts toward pluripotency.
    Kim AY; Lee EM; Lee EJ; Kim JH; Suk K; Lee E; Hur K; Hong YJ; Do JT; Park S; Jeong KS
    Cell Death Dis; 2018 Aug; 9(9):893. PubMed ID: 30166528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of the reprogramming method and pluripotency state in gamete differentiation from patient-specific human pluripotent stem cells.
    Mishra S; Kacin E; Stamatiadis P; Franck S; Van der Jeught M; Mertes H; Pennings G; De Sutter P; Sermon K; Heindryckx B; Geens M
    Mol Hum Reprod; 2018 Apr; 24(4):173-184. PubMed ID: 29471503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic modification-free reprogramming to induced pluripotent cells: fantasy or reality?
    Tada T
    Cell Stem Cell; 2008 Aug; 3(2):121-2. PubMed ID: 18682230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chromatin connections to pluripotency and cellular reprogramming.
    Orkin SH; Hochedlinger K
    Cell; 2011 Jun; 145(6):835-50. PubMed ID: 21663790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The functions of microRNAs in pluripotency and reprogramming.
    Leonardo TR; Schultheisz HL; Loring JF; Laurent LC
    Nat Cell Biol; 2012 Nov; 14(11):1114-21. PubMed ID: 23131918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.